Cancer death rates continue to decline, but 'more work ahead' toward prevention

ABSTRACT

The American Cancer Society, CDC, NCI and North American Association of Central Cancer Registries collaborated to compile the report, which provided updates on trends in cancer incidence and death rates using data on new cancer diagnoses between 2001 and 2016 and cancer deaths between 2001 and 2017. Among women of all racial and ethnic groups, cancer incidence rates increased by 0.2% annually between 2012 and 2016, driven by increases in liver cancer (AAPC, 3.7%), melanoma (1.9%), uterine cancer (1.3%), myeloma (1.2%), pancreatic cancer (1%), kidney cancer (0.6%), breast cancer (0.5%) and oral cavity and pharyngeal cancer (0.5%). Derek Raghavan, MD, PhD, president of Levine Cancer Institute at Atrium Health and HemOnc Todays Chief Medical Editor for Oncology, commented "Every day, clinicians on the line integrate the products ofbasic research with high-quality, ethical clinical trials and service delivery, balancing against the impact of rightto-try legislation, and now are putting their lives on the line in trying to maintain these gains during the [COVID-19] crisis." - by John DeRosier Disclosures The researchers report no relevant financial disclosures.